Concepedia

Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients ( > 55 to 70 years of age) with acute myelogenous leukemia

Charles L. Bennett, T J Stinson, Martin S. Tallman, Edward A. Stadtmauer, Robert Marsh, William R. Friedenberg, H M Lazarus, Lynne Kaminer, Robert Golub, Jacob M. Rowe

Annals of Oncology · 1999 · 58 citations · 14 references

DOIFull text

Open access

Concepts

References

14

2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines

Howard Ozer, Jamés O. Armitage, Charles L. Bennett et al. · Journal of Clinical Oncology · 2000 · 1K citations

, , +8

Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia

Richard M. Stone, Deborah Berg, Stephen L. George et al. · New England Journal of Medicine · 1995 · 455 citations · Full text

, , +14

A randomized placebo-controlled phase III study of granulocyte- macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)

JM Rowe, J. W. Andersen, Mazza Jj et al. · Blood · 1995 · 448 citations · Full text

, , +16

Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia

Ryuzo Ohno, Masao Tomonaga, Tohru Kobayashi et al. · New England Journal of Medicine · 1990 · 397 citations · Full text

, , +16

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

Gerhard Heil, Dieter Hoelzer, Miguel Á. Sanz et al. · Blood · 1997 · 332 citations · Full text

, , +9